AstraZeneca shares slump after Phase 3 lung cancer drug study
July 03, 2023 at 08:35 AM EDT
AstraZeneca shares fell Monday after a late-stage study on a lung cancer drug disappointed investors.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |